OmniAb (OABI) Other Non-Current Liabilities (2021 - 2026)
OmniAb's (OABI) quarterly Other Non-Current Liabilities came in at $75000.0 in Q1 2026, down 14.77% year-on-year from $88000.0 in Q1 2025, and down 3.85% on a QoQ basis from $78000.0 in Q4 2025.
OmniAb (OABI) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of Other Non-Current Liabilities data on file, last reported at $75000.0 in Q1 2026.
- On a quarterly basis, Other Non-Current Liabilities fell 14.77% year-over-year to $75000.0 in Q1 2026; TTM through Mar 2026 was $75000.0, a 14.77% decrease from a year earlier, with the FY2025 full-year figure at $78000.0, down 9.3% from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $75000.0, down from $78000.0 in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for OABI reached as high as $3.5 million in Q3 2023 and fell as low as $31000.0 in Q1 2024.
- Historically, Other Non-Current Liabilities has averaged $772571.4 across 5 years, with a median of $78000.0 in 2025.
- Across the five-year window, Other Non-Current Liabilities tumbled 99.05% in 2022 and soared 6863.04% in 2023, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $46000.0 in 2022, then surged by 6863.04% to $3.2 million in 2023, then slumped by 97.32% to $86000.0 in 2024, then slipped by 9.3% to $78000.0 in 2025, then dropped by 3.85% to $75000.0 in 2026.
- Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $75000.0 in Q1 2026, $78000.0 in Q4 2025, and $79000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | OmniAb | 261.62 Mn | 212.55 Mn | 14.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 75,000.00 |
| Dec 31, 2025 | 78,000.00 |
| Sep 30, 2025 | 79,000.00 |
| Jun 30, 2025 | 78,000.00 |
| Mar 31, 2025 | 88,000.00 |
| Dec 31, 2024 | 86,000.00 |
| Sep 30, 2024 | 53,000.00 |
| Jun 30, 2024 | 52,000.00 |
| Mar 31, 2024 | 31,000.00 |
| Dec 31, 2023 | 3.20 Mn |
| Sep 30, 2023 | 3.52 Mn |
| Jun 30, 2023 | 3.38 Mn |
| Mar 31, 2023 | 44,000.00 |
| Dec 31, 2022 | 46,000.00 |
| Dec 31, 2021 | 4.83 Mn |